204 related articles for article (PubMed ID: 20179230)
1. Melanoma MicroRNA signature predicts post-recurrence survival.
Segura MF; Belitskaya-Lévy I; Rose AE; Zakrzewski J; Gaziel A; Hanniford D; Darvishian F; Berman RS; Shapiro RL; Pavlick AC; Osman I; Hernando E
Clin Cancer Res; 2010 Mar; 16(5):1577-86. PubMed ID: 20179230
[TBL] [Abstract][Full Text] [Related]
2. microRNA-10b is a prognostic biomarker for melanoma.
Saldanha G; Elshaw S; Sachs P; Alharbi H; Shah P; Jothi A; Pringle JH
Mod Pathol; 2016 Feb; 29(2):112-21. PubMed ID: 26743475
[TBL] [Abstract][Full Text] [Related]
3. A time course-dependent metastatic gene expression signature predicts outcome in human metastatic melanomas.
Chen R; Zhang G; Zhou Y; Li N; Lin J
Diagn Pathol; 2014 Aug; 9():155. PubMed ID: 25116415
[TBL] [Abstract][Full Text] [Related]
4. Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort.
Nsengimana J; Laye J; Filia A; Walker C; Jewell R; Van den Oord JJ; Wolter P; Patel P; Sucker A; Schadendorf D; Jönsson GB; Bishop DT; Newton-Bishop J
Oncotarget; 2015 May; 6(13):11683-93. PubMed ID: 25871393
[TBL] [Abstract][Full Text] [Related]
5. Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model.
Eggermont AMM; Bellomo D; Arias-Mejias SM; Quattrocchi E; Sominidi-Damodaran S; Bridges AG; Lehman JS; Hieken TJ; Jakub JW; Murphree DH; Pittelkow MR; Sluzevich JC; Cappel MA; Bagaria SP; Perniciaro C; Tjien-Fooh FJ; Rentroia-Pacheco B; Wever R; van Vliet MH; Dwarkasing J; Meves A
Eur J Cancer; 2020 Nov; 140():11-18. PubMed ID: 33032086
[TBL] [Abstract][Full Text] [Related]
6. Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma.
Thakur R; Laye JP; Lauss M; Diaz JMS; O'Shea SJ; Poźniak J; Filia A; Harland M; Gascoyne J; Randerson-Moor JA; Chan M; Mell T; Jönsson G; Bishop DT; Newton-Bishop J; Barrett JH; Nsengimana J
Clin Cancer Res; 2019 Dec; 25(24):7424-7435. PubMed ID: 31515461
[TBL] [Abstract][Full Text] [Related]
7. Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma.
Gartrell RD; Marks DK; Rizk EM; Bogardus M; Gérard CL; Barker LW; Fu Y; Esancy CL; Li G; Ji J; Rui S; Ernstoff MS; Taback B; Pabla S; Chang R; Lee SJ; Krolewski JJ; Morrison C; Horst BA; Saenger YM
Clin Cancer Res; 2019 Apr; 25(8):2494-2502. PubMed ID: 30647081
[TBL] [Abstract][Full Text] [Related]
8. Alterations in patient plasma microRNA expression profiles following resection of metastatic melanoma.
Latchana N; DiVincenzo MJ; Regan K; Abrams Z; Zhang X; Jacob NK; Gru AA; Fadda P; Markowitz J; Howard JH; Carson WE
J Surg Oncol; 2018 Sep; 118(3):501-509. PubMed ID: 30132912
[TBL] [Abstract][Full Text] [Related]
9. miRNAs as Key Players in the Management of Cutaneous Melanoma.
Lorusso C; De Summa S; Pinto R; Danza K; Tommasi S
Cells; 2020 Feb; 9(2):. PubMed ID: 32054078
[TBL] [Abstract][Full Text] [Related]
10. Primary dermal melanoma: a unique subtype of melanoma to be distinguished from cutaneous metastatic melanoma: a clinical, histologic, and gene expression-profiling study.
Sidiropoulos M; Obregon R; Cooper C; Sholl LM; Guitart J; Gerami P
J Am Acad Dermatol; 2014 Dec; 71(6):1083-92. PubMed ID: 25262174
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a plasma-based melanoma biomarker suitable for clinical use.
Van Laar R; Lincoln M; Van Laar B
Br J Cancer; 2018 Mar; 118(6):857-866. PubMed ID: 29360813
[TBL] [Abstract][Full Text] [Related]
12. Tumour gene expression signature in primary melanoma predicts long-term outcomes.
Garg M; Couturier DL; Nsengimana J; Fonseca NA; Wongchenko M; Yan Y; Lauss M; Jönsson GB; Newton-Bishop J; Parkinson C; Middleton MR; Bishop DT; McDonald S; Stefanos N; Tadross J; Vergara IA; Lo S; Newell F; Wilmott JS; Thompson JF; Long GV; Scolyer RA; Corrie P; Adams DJ; Brazma A; Rabbie R
Nat Commun; 2021 Feb; 12(1):1137. PubMed ID: 33602918
[TBL] [Abstract][Full Text] [Related]
13. Deconvolution of transcriptomes and miRNomes by independent component analysis provides insights into biological processes and clinical outcomes of melanoma patients.
Nazarov PV; Wienecke-Baldacchino AK; Zinovyev A; Czerwińska U; Muller A; Nashan D; Dittmar G; Azuaje F; Kreis S
BMC Med Genomics; 2019 Sep; 12(1):132. PubMed ID: 31533822
[TBL] [Abstract][Full Text] [Related]
14. Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma.
Suresh S; Rabbie R; Garg M; Lumaquin D; Huang TH; Montal E; Ma Y; Cruz NM; Tang X; Nsengimana J; Newton-Bishop J; Hunter MV; Zhu Y; Chen K; de Stanchina E; Adams DJ; White RM
Cancer Discov; 2023 Jan; 13(1):194-215. PubMed ID: 36259947
[TBL] [Abstract][Full Text] [Related]
15. Author Correction: Tumour gene expression signature in primary melanoma predicts long-term outcomes.
Garg M; Couturier DL; Nsengimana J; Fonseca NA; Wongchenko M; Yan Y; Lauss M; Jönsson GB; Newton-Bishop J; Parkinson C; Middleton MR; Bishop DT; McDonald S; Stefanos N; Tadross J; Vergara IA; Lo S; Newell F; Wilmott JS; Thompson JF; Long GV; Scolyer RA; Corrie P; Adams DJ; Brazma A; Rabbie R
Nat Commun; 2022 May; 13(1):2841. PubMed ID: 35581257
[No Abstract] [Full Text] [Related]
16. A long non-coding RNA signature in glioblastoma multiforme predicts survival.
Zhang XQ; Sun S; Lam KF; Kiang KM; Pu JK; Ho AS; Lui WM; Fung CF; Wong TS; Leung GK
Neurobiol Dis; 2013 Oct; 58():123-31. PubMed ID: 23726844
[TBL] [Abstract][Full Text] [Related]
17. Functional proteomics characterization of residual breast cancer after neoadjuvant systemic chemotherapy.
Gonzalez-Angulo AM; Liu S; Chen H; Chavez-Macgregor M; Sahin A; Hortobagyi GN; Mills GB; Do KA; Meric-Bernstam F
Ann Oncol; 2013 Apr; 24(4):909-16. PubMed ID: 23139263
[TBL] [Abstract][Full Text] [Related]
18. Improved prediction of biochemical recurrence after radical prostatectomy by genetic polymorphisms.
Morote J; Del Amo J; Borque A; Ars E; Hernández C; Herranz F; Arruza A; Llarena R; Planas J; Viso MJ; Palou J; Raventós CX; Tejedor D; Artieda M; Simón L; Martínez A; Rioja LA
J Urol; 2010 Aug; 184(2):506-11. PubMed ID: 20620409
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer relapse prediction based on multi-gene RT-PCR algorithm.
Pluciennik E; Krol M; Nowakowska M; Kusinska R; Potemski P; Kordek R; Bednarek AK
Med Sci Monit; 2010 Mar; 16(3):CR132-136. PubMed ID: 20190683
[TBL] [Abstract][Full Text] [Related]
20. Signatures of microRNAs and selected microRNA target genes in human melanoma.
Philippidou D; Schmitt M; Moser D; Margue C; Nazarov PV; Muller A; Vallar L; Nashan D; Behrmann I; Kreis S
Cancer Res; 2010 May; 70(10):4163-73. PubMed ID: 20442294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
